Sign in

CIK 0002044725

  • Emerging growth company

Evommune, Inc.

Sign in to watch
Ticker
EVMN
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850742575
Phone
+1 650-223-7745
Business address
1891 PAGE MILL RD, PALO ALTO, CA
  1. 4 Planned sale Chief Business & Legal Officer sold 14,223 shares at $22.83 ($324,711)
  2. 4 Planned sale Chief Financial Officer sold 18,175 shares at $22.84 ($415,117)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 358,680 shares (grant or award)
  10. 4 Grant or award Director acquired 358,680 shares (grant or award)
  11. 4 Grant or award Director acquired 35,868 shares (grant or award)
  12. 4 Open-market buy Director bought 1,000 shares at $17.35 ($17,350)
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes President & CEO gave up 28,138 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief Scientific Officer gave up 7,513 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Business & Legal Officer gave up 13,624 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP, Operations gave up 5,074 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 13,290 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Medical Officer gave up 1,478 shares (to pay taxes)
  20. 4 Conversion Director acquired 3,367,975 shares (conversion)

Page 2 of 4 · 74 filings